This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Patient-Physician Communication  • Tobacco  • Alert me on articles by topic  Social Bookmarking   What's this?

Leif I. Solberg, MD; Stephen E. Asche, MA; Raymond G. Boyle, PhD, MPH; Jackie L. Boucher, MS, RD; Nicolaas P. Pronk, PhD

Arch Intern Med. 2005;165:656-660.

Background  Little is known about current physician-patient interactions regarding smoking cessation when a prescription is given for cessation medications.

Methods  We identified 1360 health plan members who were smokers and had filled prescriptions for bupropion hydrochloride or nicotine replacement products from March 26, 2002, through April 8, 2003. These members were surveyed 3 months after the order was filled to learn about the physician encounter that produced these prescriptions and the role of the physician in selecting the medication, supporting cessation, and achieving desirable outcomes.

Results  Among the 1035 eligible complete responses (adjusted response rate, 78%), only 36.4% reported being asked to set a specific quit date; 25.3%, to use cessation counseling; and 23.3%, to have any type of follow-up. The only physician action associated with the use of the medication was asking to set a quit date (90.7% vs 83.5%; P = .001) and no action was significantly associated with cessation. Smokers with tobacco-related chronic conditions were more likely to report physician influence but less likely to report receiving information on using the quit aid (60.6% vs 66.5%; P = .048) or being asked to set a quit date (31.7% vs 41.4%; P = .001).

Conclusions  Despite the evidence-based guideline recommendations for more support for cessation, physician support actions for those receiving prescriptions appear to be relatively infrequent and to have little influence on the use of medication by smokers or on their smoking cessation. Other environmental changes may be needed to facilitate more thorough support.

Author Affiliation: HealthPartners and HealthPartners Research Foundation, Minneapolis, Minn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cardiovascular Risk Reduction: We Have the Will, But Do We Have the Way?
Terre
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:34-37.
ABSTRACT  

Physician-patient interaction for smoking cessation medications: a dance of mutual accommodation?
Solberg et al.
J Am Board Fam Med 2006;19:251-257.
ABSTRACT | FULL TEXT